Please Wait.....
Report
India In Vitro Diagnostics Market Report and Forecast 2025-2034
Market Report I 2025-06-20 I 250 Pages I EMR Inc.
The India in vitro diagnostics market was valued at USD 2.64 Billion in 2024, driven by the rising prevalence of chronic diseases and government initiatives across the region. The market is anticipated to grow at a CAGR of 6.10% during the forecast period of 2025-2034, with the values likely to reach USD 4.77 Billion by 2034. The market is driven by increasing technological advancements like molecular diagnostics, expansion in healthcare infrastructure, and personalized medicine adoption.
India In Vitro Diagnostics Market Overview
In vitro diagnostics (IVD) encompass medical tests conducted on biological samples such as blood, urine, or tissues to detect diseases, monitor health conditions, and support clinical decision-making. These diagnostics play a vital role in preventive healthcare, disease management, and personalized medicine. The market was valued at USD 2.64 Billion in 2024 and is experiencing significant growth, driven by rising healthcare awareness, increased prevalence of chronic diseases, and advancements in diagnostic technologies. Expanding healthcare infrastructure and greater emphasis on early and accurate diagnosis further support market expansion.
India In Vitro Diagnostics Market Growth Drivers
Rising Burden of Non-Communicable Diseases to Drive Growth in the Market
The escalating prevalence of chronic and non-communicable diseases (NCDs) in India is a key driver of growth in the in vitro diagnostics market. According to the Ministry of Science and Technology, Government of India, NCDs are responsible for 53% of all deaths and contribute to 44% of disability-adjusted life years lost across the country. This substantial disease burden necessitates early and accurate diagnosis, leading to increased demand for advanced in vitro diagnostic technologies. Consequently, the rising incidence of NCDs is expected to significantly propel the expansion of the market in the coming years.
India In Vitro Diagnostics Market Trends
The market is experiencing several key trends, including in vitro diagnostics companies expanding their direct operations and local manufacturing in India, alongside the growth of disease-specific in vitro diagnostic solutions:
Localization and Direct Operations Driving Expansion in the Market
One of the significant trends include companies expanding direct operations and local manufacturing in India is reshaping the market landscape. In August 2024, Sysmex India strengthened its footprint by establishing state-of-the-art reagent manufacturing facilities and shifting from distribution partnerships to direct operations. This move enhances product availability, ensures supply chain stability, and improves customer support, collectively boosting market growth and fostering greater adoption of IVD solutions across India.
Rising Application of In Vitro Diagnostics Across Various Diseases to Elevate the India In Vitro Diagnostics Market Demand
There is a trend towards using in vitro diagnostics (IVDs) in various conditions such as diabetes, cardiovascular diseases, and infectious diseases. This is increasing the demand for precise diagnostic tools. For example, in April 2024, the World Health Organization (WHO) expanded its prequalification scope to include diabetes-related IVDs like blood glucose and HbA1c tests. This shift toward targeted diagnostics is expected to accelerate market growth by improving disease management and patient outcomes.
India In Vitro Diagnostics Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product & Services
- Reagents and Kits
- Instruments
- Software and Services
Market Breakup by Technology
- Immunodiagnostics
??- Enzyme-Linked Immunosorbent Assay (ELISA)
??- Enzyme-Linked Immunospot (ELISPOT)
??- Rapid Tests
??- Radioimmunoassay (RIA)
??- Western Blotting
??- Others
- Clinical Chemistry
??- Basic Metabolic Panels
??- Liver Panels
??- Renal Profiles
??- Lipid Profiles
??- Thyroid Function Panels
??- Electrolyte Panels
??- Specialty Chemical Tests
- Molecular Diagnostics
??- Polymerize Chain Reaction (PCR)
??- Isothermal Nucleic Acid Amplification Technology (INAAT)
??- Hybridization
??- DNA Diagnostics
??- Microarray
??- Others
- Hematology
- Microbiology
- Coagulation and Haemostasias
- Urinalysis
- Others
Market Breakup by Application
- Infectious Diseases
- Diabetes
- Oncology
- Cardiology
- Drug Testing/Pharmacogenomics
- HIV/AIDS
- Autoimmune Diseases
- Nephrology
- Others
Market Breakup by End User
- Hospitals
- Diagnostic Centers
- Point-of-Care Testing
- Academic Institutes
- Others
Market Breakup by Region
- Northern and Central
- Southern
- Eastern
- Western
India In Vitro Diagnostics Market Share
Reagents and Kits Segment is Likely to Lead the Market
The market encompasses three primary segments based on products and services, including reagents and kits, instruments, and software and services. The reagents and kits segment is expected to hold a significant share in the market, driven by its critical role in diagnostic testing. For instance, in May 2022, Cipla Limited introduced the 'RT-Direct' multiplex COVID-19 RT-PCR test kit, validated by the Indian Council of Medical Research, exemplifying the increased adoption of advanced diagnostic kits. This growth is supported by rising incidences of chronic and infectious diseases and advancements in point-of-care testing technologies.
Leading Players in the India In Vitro Diagnostics Market
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Abbott
Founded in 1888 and headquartered in Abbott Park, Illinois, Abbott is a leading global healthcare company. In February 2025, Abbott received FDA clearance for its self-collected Simpli-COLLECT molecular test for sexually transmitted infections. This innovation strengthens Abbott's role in in vitro diagnostics market by enhancing accessible, accurate molecular testing solutions.
Qiagen
Qiagen continues to drive innovation in molecular diagnostics with plans to launch three automated sample preparation instruments by 2026, including the high-throughput QIAsymphony Connect and QIAsprint Connect systems. Founded in 1984, the company leverages these technologies to enhance laboratory efficiency and precision, solidifying its significant role in the expanding in vitro diagnostics market.
Quidel Corporation
Quidel Corporation, headquartered in San Diego, California, has a significant presence in the market. The company offers MicroVue diagnostic products, including ELISA kits for assessing bone health and complement system activity. These specialized immunoassays help monitor bone turnover and immune function, supporting early diagnosis and clinical decision-making across diagnostic laboratories in India.
Danaher Corporation
Danaher Corporation is headquartered in Washington, DC, and was established in 1984. Through its subsidiary, Beckman Coulter, the company specializes in innovative in vitro diagnostic systems that support disease detection, treatment decisions, and patient monitoring. The company's advanced diagnostic technologies contribute significantly to addressing the rising burden of chronic diseases and improving healthcare outcomes.
Other key players in the market include F. Hoffmann-La Roche Ltd., Transasia Bio-Medicals Ltd., Bio-Rad Laboratories, Inc., bioMerieux SA, Thermo Fisher Scientific Inc., and Sysmex Corporation.
Key Questions Answered in the India In Vitro Diagnostics Market Report
- What was the India in vitro diagnostics market value in 2024?
- What is the India in vitro diagnostics market forecast outlook for 2025-2034?
- What major factors aid the India in vitro diagnostics market demand?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- What are the major trends in the India in vitro diagnostics market?
- Which product and services is expected to dominate the market segment?
- Which technology is projected to lead the market segment?
- Which application is anticipated to drive the market segment?
- Which end user is likely to dominate the market segment?
- Who are the key players involved in the India in vitro diagnostics market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 In Vitro Diagnostics Market Overview
3.1 Asia Pacific In Vitro Diagnostics Market Overview
3.1.1 Asia Pacific In Vitro Diagnostics Market Historical Value (2018-2024)
3.1.2 Asia Pacific In Vitro Diagnostics Market Forecast Value (2025-2034)
3.2 India In Vitro Diagnostics Market Overview
3.2.1 India In Vitro Diagnostics Market Historical Value (2018-2024)
3.2.2 India In Vitro Diagnostics Market Forecast Value (2025-2034)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 India In Vitro Diagnostics Market Landscape
5.1 India In Vitro Diagnostics Market: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 India In Vitro Diagnostics Market: Product Landscape
5.2.1 Analysis by Product & Services
5.2.2 Analysis by Technology
5.2.3 Analysis by Application
6 India In Vitro Diagnostics Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter's Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 India In Vitro Diagnostics Market Segmentation (218-2034)
7.1 India In Vitro Diagnostics Market (2018-2034) by Product & Services
7.1.1 Market Overview
7.1.2 Reagents and Kits
7.1.3 Instruments
7.1.4 Software and Services
7.2 India In Vitro Diagnostics Market (2018-2034) by Technology
7.2.1 Market Overview
7.2.2 Immunodiagnostics
7.2.2.1 Enzyme-Linked Immunosorbent Assay (ELISA)
7.2.2.2 Enzyme-Linked Immunospot (ELISPOT)
7.2.2.3 Rapid Tests
7.2.2.4 Radioimmunoassay (RIA)
7.2.2.5 Western Blotting
7.2.2.6 Others
7.2.3 Clinical Chemistry
7.2.3.1 Basic Metabolic Panels
7.2.3.2 Liver Panels
7.2.3.3 Renal Profiles
7.2.3.4 Lipid Profiles
7.2.3.5 Thyroid Function Panels
7.2.3.6 Electrolyte Panels
7.2.3.7 Specialty Chemical Tests
7.2.4 Molecular Diagnostics
7.2.4.1 Polymerize Chain Reaction (PCR)
7.2.4.2 Isothermal Nucleic Acid Amplification Technology (INAAT)
7.2.4.3 Hybridization
7.2.4.4 DNA Diagnostics
7.2.4.5 Microarray
7.2.4.6 Others
7.2.5 Hematology
7.2.6 Microbiology
7.2.7 Coagulation and Haemostasias
7.2.8 Urinalysis
7.2.9 Others
7.3 India In Vitro Diagnostics Market (2018-2034) by Application
7.3.1 Market Overview
7.3.2 Infectious Diseases
7.3.3 Diabetes
7.3.4 Oncology
7.3.5 Cardiology
7.3.6 Drug Testing/Pharmacogenomics
7.3.7 HIV/AIDS
7.3.8 Autoimmune Diseases
7.3.9 Nephrology
7.3.10 Others
7.4 India In Vitro Diagnostics Market (2018-2034) by End User
7.4.1 Market Overview
7.4.2 Hospitals
7.4.3 Diagnostic Centers
7.4.4 Point-of-Care Testing
7.4.5 Academic Institutes
7.4.6 Others
7.5 India In Vitro Diagnostics Market (2018-2034) by Region
7.5.1 Market Overview
7.5.2 Northern and Central
7.5.3 Southern
7.5.4 Eastern
7.5.5 Western
8 Regulatory Framework
9 Funding and Investment Analysis
9.1 Analysis by Funding Instances
9.2 Analysis by Type of Funding
9.3 Analysis by Funding Amount
9.4 Analysis by Leading Players
9.5 Analysis by Leading Investors
9.6 Analysis by Geography
10 Strategic Initiatives
10.1 Analysis by Partnership Instances
10.2 Analysis by Type of Initiatives
10.3 Analysis by Joint Ventures
10.4 Analysis by Leading Players
10.5 Analysis by Geography
11 Supplier Landscape
11.1 Market Share Analysis (Top 5 Companies)
11.2 F. Hoffmann-La Roche Ltd .
11.2.1 Financial Analysis
11.2.2 Product Portfolio
11.2.3 Demographic Reach and Achievements
11.2.4 Company News and Developments
11.2.5 Certifications
11.3 Transasia Bio-Medicals Ltd.
11.3.1 Financial Analysis
11.3.2 Product Portfolio
11.3.3 Demographic Reach and Achievements
11.3.4 Company News and Developments
11.3.5 Certifications
11.4 Bio-Rad Laboratories, Inc.
11.4.1 Financial Analysis
11.4.2 Product Portfolio
11.4.3 Demographic Reach and Achievements
11.4.4 Company News and Developments
11.4.5 Certifications
11.5 BioMerieux SA
11.5.1 Financial Analysis
11.5.2 Product Portfolio
11.5.3 Demographic Reach and Achievements
11.5.4 Company News and Developments
11.5.5 Certifications
11.6 Sysmex Corporation
11.6.1 Financial Analysis
11.6.2 Product Portfolio
11.6.3 Demographic Reach and Achievements
11.6.4 Company News and Developments
11.6.5 Certifications
11.7 Abbott
11.7.1 Financial Analysis
11.7.2 Product Portfolio
11.7.3 Demographic Reach and Achievements
11.7.4 Company News and Developments
11.7.5 Certifications
11.8 Thermo Fisher Scientific Inc.
11.8.1 Financial Analysis
11.8.2 Product Portfolio
11.8.3 Demographic Reach and Achievements
11.8.4 Company News and Developments
11.8.5 Certifications
11.9 QIAGEN
11.9.1 Financial Analysis
11.9.2 Product Portfolio
11.9.3 Demographic Reach and Achievements
11.9.4 Company News and Developments
11.9.5 Certifications
11.10 Quidel Corporation
11.10.1 Financial Analysis
11.10.2 Product Portfolio
11.10.3 Demographic Reach and Achievements
11.10.4 Company News and Developments
11.10.5 Certifications
11.11 Danaher Corporation
11.11.1 Financial Analysis
11.11.2 Product Portfolio
11.11.3 Demographic Reach and Achievements
11.11.4 Company News and Developments
11.11.5 Certifications
12 India In Vitro Diagnostics Market - Distribution Model (Additional Insight)
12.1 Overview
12.2 Potential Distributors
12.3 Key Parameters for Distribution Partner Assessment
13 Key Opinion Leaders (KOL) Insights (Additional Insight)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security